Clinical Trials Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. Oct 24, 2022; 13(10): 813-821
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.813
Table 1 Absolute frequencies and percentages of patients with and without severe oral mucositis by follow-up week
WeekDentoxol® (n = 55)
Control (n = 53)

No severe oral mucositis
Severe oral mucositis
No severe oral mucositis
Severe oral mucositis
P value

n
%
n
%
n
%
n
%

14994.235.84998.012.00.327
24910000.04295.524.50.131
34795.924.13076.9923.10.007a
44291.348.72970.71229.30.013a
53373.31226.71952.81747.20.055
62964.41635.61546.91753.10.125
72257.91642.11144.01456.00.280
81157.7635.3444.4555.60.320
Table 2 Odds ratio were calculated using a contingency table

Severe oral mucositis
No severe oral mucositis
Total
Dentoxol®aba + b
Controlcdc + d
Totala + cb + da + b + c + d
Table 3 Measures of clinical significance for the effect of Dentoxol® on severe oral mucositis
WeekAR
RR (95%CI)
ARR
RRR
NNT
OR (95%CI)
Dentoxol (%)
Control (%)
Dentoxol®
Dentoxol® (%)
Dentoxol® (%)
Dentoxol®
Dentoxol®
15.7722.88 (0.31-26.82)-4-188-273 (0.30-29.85)
204.55-510022-
34.0823.080.18 (0.04-0.77)1982.3150.14 (0.03-0.70)
48.729.270.3 (0.1-0.85)2170.2950.23 (0.07-0.78)
526.6747.220.56 (0.31-1.02)2143.5350.41 (0.16-1.03)
635.5653.130.67 (0.4-1.12)1833.0760.49 (0.29-1.23)
742.11560.75 (0.45-1.25)1424.8170.57 (0.21-1.58)
835.2955.560.64 (0.27-1.52)2036.4750.44 (0.08-2.27)